(Q37495281)

English

Clinical trials update from the American College of Cardiology 2009: ADMIRE-HF, PRIMA, STICH, REVERSE, IRIS, partial ventricular support, FIX-HF-5, vagal stimulation, REVIVAL-3, pre-RELAX-AHF, ACTIVE-A, HF-ACTION, JUPITER, AURORA, and OMEGA.

scientific article published on June 2009

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19468023%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Europe PubMed Central

Clinical trials update from the American College of Cardiology 2009: ADMIRE-HF, PRIMA, STICH, REVERSE, IRIS, partial ventricular support, FIX-HF-5, vagal stimulation, REVIVAL-3, pre-RELAX-AHF, ACTIVE-A, HF-ACTION, JUPITER, AURORA, and OMEGA (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19468023%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19468023%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Alison P Coletta

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19468023%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Andrew L Clark

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19468023%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Damien Cullington

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19468023%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

1 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19468023%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19468023%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19468023%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19468023%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

622-630

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19468023%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Clinical trials update from European Society of Cardiology meeting 2008: TIME-CHF, BACH, BEAUTIFUL, GISSI-HF, and HOME-HF.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

State of the art: using natriuretic peptide levels in clinical practice

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Heart failure following anterior myocardial infarction: an indication for ventricular restoration, a surgical method to reverse post-infarction remodeling

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Coronary bypass surgery with or without surgical ventricular reconstruction

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Quality of life and economic outcomes with surgical ventricular reconstruction in ischemic heart failure: results from the Surgical Treatment for Ischemic Heart Failure trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

The heart failure revascularisation trial (HEART): rationale, design and methodology.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Clinical trials update from Heart Rhythm 2008 and Heart Failure 2008: ATHENA, URGENT, INH study, HEART and CK-1827452.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Clinical trials update from the American College of Cardiology 2008: CARISMA, TRENDS, meta-analysis of Cox-2 studies, HAT, ON-TARGET, HYVET, ACCOMPLISH, MOMENTUM, PROTECT, HORIZON-HF and REVERSE.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Patients with heart failure who require an implantable defibrillator should have cardiac resynchronisation routinely

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

The timing of development and subsequent clinical course of heart failure after a myocardial infarction.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

A novel protective effect of erythropoietin in the infarcted heart

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Intravenous recombinant human relaxin in compensated heart failure: a safety, tolerability, and pharmacodynamic trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Effect of clopidogrel added to aspirin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Clinical trials update from the Heart Failure Society of America and the American Heart Association meetings in 2008: SADHART-CHF, COMPARE, MOMENTUM, thyroid hormone analogue study, HF-ACTION, I-PRESERVE, beta-interferon study, BACH, and ATHENA.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

A randomized trial of rosuvastatin in the prevention of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Study of Heart and Renal Protection (SHARP)

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Rosuvastatin in older patients with systolic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Effect of fish oil on arrhythmias and mortality: systematic review

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Long term vagal stimulation in patients with advanced heart failure First experience in man

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP071

21 January 2018

Identifiers

10.1093/EURJHF/HFP071

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19468023%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19468023%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37495281&oldid=1410021263"